Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Fluorouracil With or Without Mitomycin in Treating Patients With Peritoneal Cancer
This study is ongoing, but not recruiting participants.
Study NCT00006112 Information provided by National Cancer Institute (NCI)
First Received: August 3, 2000 Last Updated: February 6, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Carcinoma of the Appendix
Colorectal Cancer
Peritoneal Cavity Cancer
Additional conditions recognized in this trial
Carcinoma
Colonic Neoplasms
Colorectal Neoplasms
Peritoneal Neoplasms
More general conditions related to this trial
Abdominal Neoplasms
Colonic Diseases
Digestive System Diseases
Digestive System Neoplasms
Gastrointestinal Diseases
Gastrointestinal Neoplasms
Intestinal Diseases
Intestinal Neoplasms
Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Glandular and Epithelial
Peritoneal Diseases
Rectal Diseases
Interventions listed in this trial
chemotherapy
fluorouracil
leucovorin calcium
mitomycin C
Additional drug interventions recognized in this trial
Leucovorin
Mitomycin
Mitomycins
More general drug interventions related to this trial
Alkylating Agents
Antibiotics, Antineoplastic
Antimetabolites
Antimetabolites, Antineoplastic
Antineoplastic Agents
Enzyme Inhibitors
Growth Substances
Immunologic Factors
Immunosuppressive Agents
Micronutrients
Molecular Mechanisms of Pharmacological Action
Nucleic Acid Synthesis Inhibitors
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Vitamin B Complex
Vitamins
Sponsors listed in this trial
Institut Gustave Roussy
Back to top of Main Content
